1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow NDV-HXP-S 3μg: new trials by email Literature Review of NDV-HXP-S 3μg trials Research Report on NDV-HXP-S 3μg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial of the COVID-19 Vaccine (Recombinant, Inactivated) in Brazil NDV-HXP-S 1μg, NDV-HXP-S 3μg, NDV-HXP-S 10μg - Coronavirus Infections, Healthy | Phase 1 | Completed | Butantan Institute | 320 | 2021-07-09 | 2023-08-21 |
COVID-19 (1) · Coronavirus Infections (1)
Brazil (1)
Fernanda Castro Boulos, MD,PhD (1)